Criticisms of drugs in early development for the treatment of depression: what can be improved?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Criticisms of drugs in early development for the treatment of depression: what can be improved?

Published:2014-12-20 Issue:4 Volume:24 Page:445-453
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Wang Sheng-Min¹²,Han Changsu³,Pae Chi-Un¹⁴

Affiliation:

1. 1The Catholic University of Korea College of Medicine, Department of Psychiatry, Seoul, Republic of Korea

2. 2The Catholic University of Korea College of Medicine, Seoul St. Mary’s Hospital, International Health Care Center, Seoul, Republic of Korea

3. 3Korea University, College of Medicine, Department of Psychiatry, Seoul, Republic of Korea

4. 4Duke University Medical Center, Department of Psychiatry and Behavioural Sciences, Durham, NC, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.985784

Reference64 articles.

1. Current investigational drugs for major depression

2. Meta-Analysis of Selective Serotonin Reuptake Inhibitor–Associated QTc Prolongation

3. The Serotonin Syndrome

4. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Можливості фармакотерапії постінсультної депресії: новий погляд на стару проблему;INTERNATIONAL NEUROLOGICAL JOURNAL;2023-02-13

2. Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties;Phytomedicine;2021-09

3. Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis;Clinical Psychopharmacology and Neuroscience;2021-05-31

4. A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat;Clinical Psychopharmacology and Neuroscience;2021-02-28

5. Novel antagonists of 5-HT6 and/or 5-HT7 receptors affect the brain monoamines metabolism and enhance the anti-immobility activity of different antidepressants in rats;Behavioural Brain Research;2019-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3